Centric Wealth Management Maia Biotechnology, Inc. Transaction History
Centric Wealth Management
- $350 Million
- Q4 2024
A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 68,219 shares of MAIA stock, worth $126,205. This represents 0.04% of its overall portfolio holdings.
Number of Shares
68,219
Previous 68,219
-0.0%
Holding current value
$126,205
Previous $191,000
29.84%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA583KShares$1.08 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN241KShares$445,5130.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$365,4190.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$145,2630.0% of portfolio
-
State Street Corp Boston, MA53.3KShares$98,5120.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...